The Clorox Company

The Clorox Company

CLXยทNYSE

$88.53

-1.2%
Consumer DefensiveHousehold & Personal Products

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.

At a Glance

Live Snapshot
Market Cap$10.71B
EPS6.5600
P/E Ratio13.50
Earnings Date07/30/2026
3Y-10.0%
5Y-10.0%
10Y+23.0%
3Y-6.0%
5Y-4.0%
10Y+20.0%
3Y-34.0%
5Y-47.0%
10Y+62.0%
clx

The Clorox Company Funding & Solvency Profile

CLX ยท NYSE
Cash & Cash Equivalents167.00M
Net Receivables821.00M
Inventory523.00M
Other Current Assets97.00M
Total Current Assets2 B
Property, Plant & Equipment1.60B
Goodwill & Intangible Assets1.79B
Long-Term Investments0.00
Other Non-Current Assets558.00M
Total Non-Current Assets2 B
Total Assets
5.56B

Financial Health Analysis

Current Ratio

0.84x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

10.54x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-311000000

Negative working capital indicates short-term liabilities exceed short-term assetsโ€”potential liquidity stress.

Asset Composition

29% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

The Clorox Company Balance Sheet

CLX โ€ข NYSE

The Clorox Company Balance SheetJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010Jun 2009Jun 2008Jun 2007Jun 2006
ASSETS
CURRENT ASSETS
167M
202M
367M
183M
319M
871M
111M
131M
418M
401M
382M
329M
299M
267M
259M
87M
206M
214M
182M
192M
167M
202M
367M
183M
319M
871M
111M
131M
418M
401M
382M
329M
299M
267M
259M
87M
206M
214M
182M
192M
821M
695M
688M
681M
604M
648M
631M
600M
565M
569M
519M
546M
580M
576M
525M
540M
486M
505M
460M
435M
805M
659M
688M
681M
604M
648M
631M
600M
565M
569M
519M
546M
580M
576M
525M
540M
486M
505M
460M
435M
16M
36M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
523M
637M
696M
755M
752M
454M
512M
506M
459M
443M
385M
386M
394M
384M
382M
367M
366M
384M
309M
292M
0.0
0.0
0.0
106M
154M
47M
51M
74M
72M
72M
39M
42M
41M
43M
0.0
40M
0.0
45M
0.0
0.0
97M
88M
77M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
104M
92M
106M
106M
113M
530M
122M
150M
81M
88M
1.6B
1.6B
1.8B
1.7B
1.8B
2B
1.3B
1.3B
1.5B
1.5B
1.4B
1.4B
1.4B
1.4B
1.3B
1.1B
1.2B
1.2B
1B
1B
NON-CURRENT ASSETS
1.6B
1.7B
1.7B
1.7B
1.6B
1.4B
1B
996M
931M
906M
918M
977M
1B
1.1B
1B
979M
955M
960M
976M
1B
1.2B
1.2B
1.3B
1.6B
1.6B
1.6B
1.6B
1.6B
1.2B
1.2B
1.1B
1.1B
1.1B
1.1B
1.1B
1.7B
1.6B
1.7B
855M
744M
566M
681M
712M
884M
918M
894M
912M
929M
722M
735M
585M
611M
627M
642M
633M
646M
662M
683M
348M
604M
1.8B
1.9B
2B
2.4B
2.5B
2.5B
2.5B
2.5B
1.9B
1.9B
1.7B
1.7B
1.7B
1.8B
1.7B
1.9B
2.3B
2.3B
1.4B
1.3B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
14M
0.0
558M
545M
462M
315M
378M
328M
274M
222M
210M
187M
165M
174M
138M
144M
142M
144M
149M
158M
186M
257M
4B
4.1B
4.1B
4.4B
4.5B
4.2B
3.8B
3.7B
3.1B
3B
2.7B
2.9B
2.9B
3B
2.9B
3.4B
3.4B
3.5B
2.6B
2.6B
5.6B
5.8B
5.9B
6.2B
6.3B
6.2B
5.1B
5.1B
4.6B
4.5B
4.2B
4.3B
4.3B
4.4B
4.2B
4.6B
4.6B
4.7B
3.7B
3.6B
LIABILITIES
CURRENT LIABILITIES
865M
975M
1.2B
979M
1.1B
746M
655M
636M
617M
598M
565M
548M
538M
502M
464M
483M
467M
470M
329M
329M
838M
950M
1B
960M
930M
575M
507M
507M
501M
490M
431M
440M
413M
412M
423M
409M
381M
418M
329M
329M
27M
25M
144M
19M
162M
171M
148M
129M
116M
108M
134M
108M
125M
90M
41M
74M
86M
52M
0.0
0.0
784M
321M
353M
314M
364M
320M
231M
211M
226M
245M
256M
253M
239M
244M
442M
491M
472M
440M
507M
474M
4M
4M
50M
237M
300M
0.0
396M
199M
804M
523M
395M
718M
202M
1.2B
459M
671M
998M
755M
574M
308M
87M
84M
87M
78M
81M
64M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
121M
0.0
0.0
25M
9M
0.0
0.0
0.0
31M
8M
29M
5M
41M
74M
86M
52M
0.0
0.0
179M
190M
262M
176M
219M
288M
158M
154M
162M
192M
189M
119M
155M
165M
0.0
0.0
0.0
0.0
17M
19M
1.9B
1.6B
1.9B
1.8B
2.1B
1.4B
1.4B
1.2B
1.8B
1.6B
1.4B
1.6B
1.1B
2.1B
1.4B
1.6B
1.9B
1.7B
1.4B
1.1B
NON-CURRENT LIABILITIES
2.5B
2.5B
2.5B
2.5B
2.5B
2.8B
2.3B
2.3B
1.4B
1.8B
1.8B
1.6B
2.2B
1.6B
2.1B
2.1B
2.2B
2.7B
1.5B
2B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
36M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
20M
22M
28M
66M
67M
62M
50M
72M
61M
82M
95M
103M
119M
119M
140M
24M
23M
97M
90M
129M
351M
848M
825M
791M
834M
767M
780M
778M
770M
784M
750M
768M
742M
739M
619M
677M
640M
632M
516M
547M
3.2B
3.7B
3.6B
3.6B
3.7B
3.9B
3.1B
3.1B
2.2B
2.7B
2.6B
2.5B
3B
2.4B
2.9B
2.8B
2.8B
3.4B
2.1B
2.6B
392M
418M
397M
392M
382M
342M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.1B
5.3B
5.6B
5.4B
5.7B
5.3B
4.6B
4.3B
4B
4.2B
4B
4.1B
4.2B
4.5B
4.2B
4.5B
4.8B
5.1B
3.5B
3.8B
SHAREHOLDERS' EQUITY
-1.4B
-1.2B
-1.2B
-1.3B
-1.4B
-3.3B
-3.2B
-2.7B
-2.4B
-2.3B
-2.2B
-2B
-1.9B
-1.9B
-1.8B
-1.2B
-1.2B
-1.3B
-445M
-4.5B
131M
131M
131M
131M
131M
159M
159M
159M
159M
159M
159M
159M
159M
159M
159M
159M
159M
159M
159M
250M
1.3B
1.3B
1.2B
1.2B
1.2B
1.1B
1B
975M
928M
868M
775M
709M
661M
633M
632M
617M
579M
534M
481M
397M
432M
250M
583M
1B
1B
3.6B
3.2B
2.8B
2.4B
2.2B
1.9B
1.7B
1.6B
1.4B
1.1B
920M
640M
386M
185M
3.9B
-157M
-155M
-493M
-479M
-546M
-640M
-602M
-547M
-543M
-570M
-502M
-417M
-367M
-396M
-250M
-371M
-347M
-179M
-209M
-215M
321M
328M
220M
556M
411M
908M
559M
726M
542M
297M
118M
154M
146M
-135M
-86M
83M
-175M
-370M
171M
-156M
482M
492M
388M
729M
592M
908M
559M
726M
542M
297M
118M
154M
146M
-135M
-86M
83M
-175M
-370M
171M
-156M
161M
164M
168M
173M
181M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
SUMMARY
5.6B
5.8B
5.9B
6.2B
6.3B
6.2B
5.1B
5.1B
4.6B
4.5B
4.2B
4.3B
4.3B
4.4B
4.2B
4.6B
4.6B
4.7B
3.7B
3.6B
2.9B
2.9B
2.9B
3.1B
3.2B
3.1B
2.7B
2.5B
2.2B
2.3B
2.2B
2.3B
2.4B
2.7B
2.6B
2.8B
3.1B
3.5B
2B
2.3B
2.7B
2.7B
2.6B
2.9B
2.8B
2.3B
2.6B
2.4B
1.8B
1.9B
1.8B
2B
2.1B
2.5B
2.3B
2.7B
2.9B
3.3B
1.9B
2.1B
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379
121,980,379

SEC Filings

CLX - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 28, 2026
May 26, 2026
2026
8-K

8-K 2026

N/A

May 11, 2026
May 06, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 30, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 30, 2026
2026
8-K

8-K 2026

N/A

April 01, 2026
April 01, 2026
2026
8-K

8-K 2026

N/A

March 10, 2026
March 06, 2026
2026
10-Q

10-Q 2025 Q4

Q4

February 03, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 03, 2026
February 03, 2026
2026
8-K

8-K 2026

N/A

January 22, 2026
January 17, 2026
2026
8-K

8-K 2025

N/A

November 20, 2025
November 19, 2025
2025
Showing 1 to 10 of 441 filings